Amneal Pharmaceuticals Inc. (AMRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Amneal Pharmaceuticals In...

    NASDAQ: AMRX · Real-Time Price · USD
    9.62
    0.07 (0.73%)
    At close: Sep 05, 2025, 3:59 PM
    9.57
    -0.52%
    After-hours: Sep 05, 2025, 07:47 PM EDT

    Amneal Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.79B 2.39B 2.21B 2.09B
    Cost of Revenue
    		 1.77B 1.53B 1.43B 1.31B
    Gross Profit
    		 1.02B 820.57M 791.46M 783.95M
    Operating Income
    		 249.33M 204.37M -94.93M 152.72M
    Interest Income
    		 n/a n/a 158.38M 136.32M
    Pretax Income
    		 -55.01M -40.27M -248.13M 31.37M
    Net Income
    		 -116.89M -83.99M -129.99M 10.62M
    Selling & General & Admin
    		 476.44M 429.68M 399.7M 365.5M
    Research & Development
    		 190.71M 194.75M 200.05M 209.56M
    Other Expenses
    		 103.96M 18.74M -3.96M 41.19M
    Operating Expenses
    		 771.11M 659.5M 595.79M 616.26M
    Interest Expense
    		 258.6M 210.63M 158.38M 136.32M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 2.54B 2.19B 2.02B 1.94B
    Income Tax Expense
    		 18.86M 8.45M 6.66M 11.2M
    Shares Outstanding (Basic)
    		 308.98M 174.99M 150.94M 148.92M
    Shares Outstanding (Diluted)
    		 308.98M 176.14M 150.94M 151.82M
    EPS (Basic)
    		 -0.38 -0.48 -0.86 0.07
    EPS (Diluted)
    		 -0.38 -0.48 -0.86 0.07
    EBITDA
    		 439.77M 399.76M 150.43M 401.1M
    EBIT
    		 203.58M 170.36M -89.75M 167.69M
    Depreciation & Amortization
    		 236.19M 229.4M 240.18M 233.41M

    Add to Watchlist